KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Asset Writedowns and Impairment (2016 - 2025)

Omega Healthcare Investors' Asset Writedowns and Impairment history spans 11 years, with the latest figure at $5.9 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 240.99% year-over-year to $5.9 million; the TTM value through Dec 2025 reached $2.3 million, down 90.2%, while the annual FY2025 figure was $2.3 million, 90.2% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $5.9 million at Omega Healthcare Investors, up from -$19.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $80.3 million in Q4 2023 and bottomed at -$19.0 million in Q3 2025.
  • The 5-year median for Asset Writedowns and Impairment is $4.7 million (2022), against an average of $11.7 million.
  • The largest annual shift saw Asset Writedowns and Impairment surged 23473.33% in 2021 before it tumbled 322.42% in 2023.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $49.7 million in 2021, then tumbled by 31.43% to $34.1 million in 2022, then skyrocketed by 135.59% to $80.3 million in 2023, then crashed by 97.84% to $1.7 million in 2024, then surged by 240.99% to $5.9 million in 2025.
  • Per Business Quant, the three most recent readings for OHI's Asset Writedowns and Impairment are $5.9 million (Q4 2025), -$19.0 million (Q3 2025), and $14.2 million (Q2 2025).